2 completed, 1 active not recruiting, 1 not yet recruiting, 1 terminated. 5 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 2, Active not recruiting 1, Not yet recruiting 1, Terminated 1 |
| Phase 3 | 1 | Completed 1 |
Follow Hematologic Disorder: new trials by email Literature Review of Hematologic Disorder trials Research Report on Hematologic Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Golidocitinib for Refractory Immune-related Hematologic Toxicities of Advanced Lung Cancer golidocitinib - IrAE, Hematologic Disorder | Phase 2 | Not yet recruiting | The First Affiliated Hospital of Guangzhou Medical University | 16 | 2026-02-01 | 2025-12-26 |
| Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL) Lenalidomide, Influenza Vaccine, Pneumovax Vaccine - Hematologic Disorder | Phase 2 | Terminated | M.D. Anderson Cancer Center | 3 | 2014-11-24 | 2018-09-20 |
| Prophylaxis of Hematologic Complications With Naderin in First-Line Breast Cancer Chemotherapy Naderin, AC Chemotherapy - Breast Cancer, Hematologic Disorder | Phase 2 / Phase 3 | Completed | MIPO Clinic | 79 | 2014-01-01 | 2026-06-30 |
| Dexamethasone Dyspnea Study Dexamethasone, Placebo, Questionnaires - Advanced Cancers, Hematologic Disorder | Phase 2 | Completed | M.D. Anderson Cancer Center | 52 | 2013-01-01 | 2021-02-17 |
| SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP) SGN-35 - CD-30 Positive Anaplastic Large T-cell Cutaneous Lymphoma, Lymphoma, Primary Cutaneous Anaplastic Large Cell | Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 79 | 2011-06-01 | 2026-07-16 |
Hematologic Diseases (5) · Agammaglobulinemia (1) · Breast Neoplasms (1) · Dyspnea (1) · Influenza, Human (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukopenia (1) · Lung Neoplasms (1) · Lymphoma (1) · Lymphoma, Primary Cutaneous Anaplastic Large Cell (1) · Lymphoma, T-Cell, Cutaneous (1) · Lymphomatoid Papulosis (1) · Mycosis Fungoides (1) · Neoplasm Metastasis (1)
Hemic and Lymphatic Diseases (5) · Neoplasms (4) · Pathological Conditions, Signs and Symptoms (3) · Respiratory Tract Diseases (3) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphatic Diseases (2) · Lymphoproliferative Disorders (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Pathologic Processes (2) · Blood Protein Disorders (1) · Breast Diseases (1) · Chronic Disease (1) · Cytopenia (1)
Brentuximab Vedotin (1) · Calcium Dobesilate (1) · Cyclophosphamide (1) · Dexamethasone (1) · Doxorubicin (1) · Influenza Vaccines (1) · Lenalidomide (1) · SARS-CoV-2 inactivated vaccines (1) · Sugars (1) · Surveys and Questionnaires (1) · sodium nucleinate (1)
M.D. Anderson Cancer Center (3) · MIPO Clinic (1) · The First Affiliated Hospital of Guangzhou Medical University (1)
United States (3) · China (1)
Alessandra Ferrajoli, MD,BS (1) · Auris O Huen, MD (1) · David Hui, MD (1)